Alzheimer’s disease and vascular dementia are the two most common forms of dementia, but they damage the brain in fundamentally different ways. Alzheimer’s accounts for 60% to 80% of all dementia cases, while vascular dementia alone accounts for about 5% to 10%. The distinction matters because they have different causes, different symptom patterns, and different approaches to management.
What Happens in the Brain
Alzheimer’s disease is driven by abnormal protein buildup. Sticky clumps of a protein called amyloid form plaques between brain cells, while twisted fibers of another protein called tau create tangles inside neurons. These plaques and tangles are the primary physical cause of the cognitive decline in Alzheimer’s, gradually destroying brain cells and the connections between them.
Vascular dementia, by contrast, is caused by reduced blood flow to the brain. This can happen through several mechanisms: large arteries feeding the brain narrow with plaque buildup, small blood vessels deep in the brain stiffen and leak, or tiny strokes destroy pockets of tissue. When blood vessels become damaged, plasma proteins leak through vessel walls into surrounding brain tissue, creating areas of injury called white matter lesions. These lesions, along with small infarcts (areas of dead tissue from blocked blood flow), accumulate over time and impair thinking.
The two diseases also interact in ways that complicate the picture. High blood pressure damages small blood vessels, and the resulting tissue changes can actually promote amyloid plaque formation. High blood sugar increases compounds that are found in high concentrations within plaques and tangles and help amyloid clump together. So cardiovascular problems don’t just cause vascular dementia on their own; they can accelerate Alzheimer’s pathology too.
How Symptoms Differ
The earliest symptoms often point to which type of dementia someone has, though there’s overlap. Alzheimer’s typically announces itself through short-term memory problems: repeating questions, getting lost in familiar places, and gradually losing the ability to recognize friends and family. As it progresses, communication breaks down and behavior becomes increasingly impulsive.
Vascular dementia tends to hit executive function first. That means trouble following instructions, difficulty learning new information, and poor judgment. Memory problems occur too, but the hallmark early signs are more about planning, organizing, and processing than about forgetting names or recent conversations. Some people with vascular dementia also experience hallucinations or delusions, which are less typical in early Alzheimer’s.
The pattern of decline also differs. Alzheimer’s is generally a slow, steady slide, though the rate varies considerably from person to person. Some people decline rapidly while others progress slowly, and there’s evidence that the early stages tend to be slower with acceleration later in the disease. Vascular dementia more often follows a “step-wise” pattern: a person’s abilities drop suddenly (often after a stroke or vascular event), stabilize for a while, then drop again with the next event. This staircase pattern isn’t universal, though. When vascular dementia is caused by chronic small vessel disease rather than distinct strokes, the decline can look more gradual and harder to distinguish from Alzheimer’s.
Risk Factors for Each Type
The strongest known genetic risk factor for Alzheimer’s is a gene variant called APOE ε4. Carrying one copy increases your risk; carrying two copies increases it substantially. This gene variant is also linked to high cholesterol and heart disease, which hints at the deep connection between vascular health and brain health. Women tend to experience faster cognitive decline than men once Alzheimer’s develops, and higher levels of education, paradoxically, are associated with a more rapid decline once symptoms appear (likely because the disease is already more advanced by the time it becomes noticeable).
Vascular dementia risk tracks closely with cardiovascular risk. High blood pressure, diabetes, smoking, high cholesterol, and a history of stroke are the major drivers. These factors damage blood vessels throughout the body, and the brain’s delicate small vessels are particularly vulnerable. Managing these conditions is the single most important thing you can do to reduce vascular dementia risk, and it likely offers some protection against Alzheimer’s as well, since cardiovascular damage promotes subclinical brain injury that makes dementia of any type more likely to produce noticeable symptoms.
How Doctors Tell Them Apart
Brain imaging is one of the most useful tools for distinguishing the two. On MRI, vascular dementia shows widespread white matter changes, areas of damaged tissue that reflect chronic blood flow problems. In one study, MRI detected white matter changes in all patients with vascular dementia but in only about a third of Alzheimer’s patients. CT scans showed an even starker difference, picking up changes in nearly all vascular dementia cases but almost none of the Alzheimer’s cases. Alzheimer’s, meanwhile, tends to show shrinkage of the hippocampus, the brain’s memory center, on imaging.
Clinical history also guides diagnosis. A sudden onset of cognitive problems following a known stroke strongly suggests vascular dementia. A gradual, progressive memory decline with no clear vascular events points more toward Alzheimer’s. But in practice, the distinction is often blurry. The clinical presentations overlap, and there is no consensus on how to diagnose cases where both diseases are present.
When Both Are Present: Mixed Dementia
A significant number of people with dementia don’t have just one type. Autopsy studies show that mixed dementia, where Alzheimer’s pathology and vascular damage coexist in the same brain, has a prevalence of about 22% among elderly people with dementia. Vascular lesions like white matter damage and small infarcts are common in people diagnosed with Alzheimer’s during life, and Alzheimer’s hallmarks like plaques and tangles are frequently found in the brains of people diagnosed with vascular dementia.
These two pathologies don’t just coexist passively. They interact, each lowering the threshold at which the other produces noticeable symptoms. Someone with a modest amount of Alzheimer’s pathology might function well, but add vascular damage on top and cognitive decline becomes apparent. This overlap is one reason why controlling cardiovascular risk factors matters even for people whose primary diagnosis is Alzheimer’s.
Treatment and Management
Alzheimer’s treatment focuses on slowing cognitive decline. Medications that boost a brain chemical involved in memory and learning are the standard approach, and newer therapies that target amyloid plaques directly have recently become available for people in early stages.
Vascular dementia management centers on preventing further vascular damage. That means aggressively controlling blood pressure, managing diabetes, lowering cholesterol, quitting smoking, and treating any underlying heart conditions. The goal is to stop the accumulation of new brain injuries, since existing damage generally can’t be reversed. Some of the medications used for Alzheimer’s are also prescribed for vascular dementia, with modest benefit.
Because mixed pathology is so common, many people benefit from both approaches: medications that support cognitive function alongside rigorous cardiovascular risk management. Getting the right diagnosis, or recognizing that both processes may be at work, is essential for choosing the most effective treatment strategy.